AIBL’s journal articles
Below is an archive of AIBL’s refereed journal articles as available on Pubmed. This does not include abstracts, conference proceedings or other external publications.
ALL PUBLICATIONS
ALL NEWS & EVENTS
The Association Between Alzheimer’s Disease-Related Markers and Physical Activity in Cognitively Normal Older Adults
Pedrini S, Chatterjee P, Nakamura A, Tegg M, Hone E, Rainey-Smith S, Rowe CC, Doré V, Villemagne VL, Ames D, Kaneko N, Gardener S, Taddei K, Fernando B, Martins I, Bharadwaj P, Sohrabi HR, Masters CL, Brown B, Martins RN, and the AIBL Research Group.
A robust harmonization approach for cognitive data from multiple aging and dementia cohorts.
Joseph Giorgio, Ankeet Tanna, Maura Malpetti, Simon R. White, Jingshen Wang, Suzanne Baker, Susan Landau, Tomotaka Tanaka, Christopher Chen, James B. Rowe, John O’Brien, Jurgen Fripp, Michael Breakspear, William Jagust, Zoe Kourtzi, for the Alzheimer’s Disease Neuroimaging Initiative, Australian Imaging Biomarkers and Lifestyle flagship study
Sex-dependent cholinergic effects on amyloid pathology: A translational study
German-Castelan L, Shanks HRC, Gros R, Saito T, Saido TC, Saksida LM, Bussey TJ, Prado MAM, Schmitz TW, Prado VF; Australian Imaging Biomarkers and Lifestyle flagship study of ageing.
CenTauR: Toward a universal scale and masks for standardizing tau imaging studies
Villemagne VL, Leuzy A, Bohorquez SS, Bullich S, Shimada H, Rowe CC, Bourgeat P, Lopresti B, Huang K, Krishnadas N, Fripp J, Takado Y, Gogola A, Minhas D, Weimer R, Higuchi M, Stephens A, Hansson O, Doré V ; Alzheimer’s Disease Neuroimaging Initiative and the AIBL research group (2023).
Plasma p217+ tau vs NAV4694 amyloid and MK6240 tau PET across the Alzheimer continuum
Doré V, Doecke JD, Saad ZS, Triana-Baltzer G, Slemmon R, Krishnadas N, Bourgeat P, Huang K, Burnham S, Fowler C, Rainey-Smith SR, Bush A, Ward L, Robertson J, Martins RN, Masters CL, Villemagne VL, Fripp J, Kolb HC, Rowe CC (2022).
Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume
Milicic L, Vacher M, Porter T, Doré V, Burnham SC, Bourgeat P, Shishegar R, Doecke J, Armstrong NJ, Tankard R, Maruff P, Masters CL, Rowe CC, Villemagne VL, Laws SM (2022).
Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer’s disease continuum: A cross-sectional and longitudinal study in the AIBL cohort
Chatterjee, P, Pedrini, S, Doecke, JD, et al (2022).
BDNF VAL66MET polymorphism and memory decline across the spectrum of Alzheimer’s disease
Lim YY, Laws SM, Perin S, Pietrzak RH, Fowler C, Masters CL, Maruff P; AIBL Research Group (2021).
Aggregation of Abnormal Memory Scores and Risk of Incident Alzheimer’s Disease Dementia: A Measure of Objective Memory Impairment in Amnestic Mild Cognitive Impairment
Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D (2021).
Influence of comorbidity of cerebrovascular disease and amyloid-β on Alzheimer’s disease
Yassi N, Hilal S, Xia Y, Lim YY, Watson R, Kuijf H, Fowler C, Yates P, Maruff P, Martins R, Ames D, Chen C, Rowe CC, Villemagne VL, Salvado O, Desmond PM, Masters CL (2020).
Stay up to date with the latest news from the AIBL study.